J. Bourbon, O. Boucherat, B. Chailley-heu, and C. Delacourt, Control Mechanisms of Lung Alveolar Development and Their Disorders in Bronchopulmonary Dysplasia, Pediatric Research, vol.106, issue.5 Part 2, pp.38-46, 2005.
DOI : 10.1203/01.PDR.0000159630.35883.BE

J. Kinsella, A. Greenough, and S. Abman, Bronchopulmonary dysplasia, The Lancet, vol.367, issue.9520, pp.1421-1431, 2006.
DOI : 10.1016/S0140-6736(06)68615-7

E. Baraldi and M. Filippone, Chronic Lung Disease after Premature Birth, New England Journal of Medicine, vol.357, issue.19, pp.1946-1955, 2007.
DOI : 10.1056/NEJMra067279

S. Kallapur and A. Jobe, Contribution of inflammation to lung injury and development, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.91, issue.2, pp.132-135, 2006.
DOI : 10.1136/adc.2004.068544

B. Yoon, R. Romero, J. Jun, K. Park, and J. Park, Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-??, interleukin-1??, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia, American Journal of Obstetrics and Gynecology, vol.177, issue.4, pp.825-830, 1997.
DOI : 10.1016/S0002-9378(97)70276-X

V. Zanardo, V. Savio, C. Giacomin, A. Rinaldi, and F. Marzari, Relationship Between Neonatal Leukemoid Reaction and Bronchopulmonary Dysplasia in Low-Birth-Weight Infants: A Cross-Sectional Study, American Journal of Perinatology, vol.19, issue.7, pp.379-386, 2002.
DOI : 10.1055/s-2002-35612

R. Hsiao and S. Omar, Outcome of Extremely Low Birth Weight Infants With Leukemoid Reaction, PEDIATRICS, vol.116, issue.1, pp.43-51, 2005.
DOI : 10.1542/peds.2004-1379

T. Merritt, C. Cochrane, K. Holcomb, B. Bohl, and M. Hallman, Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia., Journal of Clinical Investigation, vol.72, issue.2, pp.656-666, 1983.
DOI : 10.1172/JCI111015

R. Auten, . Jr, S. Mason, D. Tanaka, K. Welty-wolf et al., Anti-neutrophil chemokine preserves alveolar development in hyperoxiaexposed newborn rats, Am J Physiol Lung Cell Mol Physiol, vol.281, pp.336-344, 2001.

T. Torphy, Phosphodiesterase Isozymes, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.2, pp.351-370, 1998.
DOI : 10.1164/ajrccm.157.2.9708012

A. Bender and J. Beavo, Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use, Pharmacological Reviews, vol.58, issue.3, pp.488-520, 2006.
DOI : 10.1124/pr.58.3.5

M. Giembycz, An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease, British Journal of Clinical Pharmacology, vol.17, issue.2, pp.138-152, 2006.
DOI : 10.1016/S0165-6147(02)02089-8

D. Spina, Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease, Drugs, vol.161, issue.23, pp.2575-2594, 2003.
DOI : 10.2165/00003495-200363230-00002

P. Burri, J. Dbaly, and E. Weibel, The postnatal growth of the rat lung. I. Morphometry, The Anatomical Record, vol.41, issue.4, pp.711-730, 1974.
DOI : 10.1002/ar.1091780405

Y. Visser, F. Walther, E. Laghmani, S. Van-wijngaarden, and K. Nieuwland, Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury, European Respiratory Journal, vol.31, issue.3, 2007.
DOI : 10.1183/09031936.00071307

H. Tang, Y. Song, J. Chen, J. Chen, and P. Wang, Upregulation of Phosphodiesterase-4 in the Lung of Allergic Rats, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.8, pp.823-828, 2005.
DOI : 10.1164/rccm.200406-771OC

E. Lopez, O. Boucherat, M. Franco-montoya, J. Bourbon, and C. Delacourt, Nitric Oxide Donor Restores Lung Growth Factor and Receptor Expression in Hyperoxia-Exposed Rat Pups, American Journal of Respiratory Cell and Molecular Biology, vol.34, issue.6, pp.738-745, 2006.
DOI : 10.1165/rcmb.2005-0254OC

H. Deng, S. Mason, R. Auten, and . Jr, Lung Inflammation in Hyperoxia Can Be Prevented By Antichemokine Treatment in Newborn Rats, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.6, pp.2316-2323, 2000.
DOI : 10.1164/ajrccm.162.6.9911020

S. Horst, G. Wagenaar, E. De-boer, M. Van-gastelen, and J. Meijers, Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury, Journal of Applied Physiology, vol.97, issue.5, pp.2014-2019, 2004.
DOI : 10.1152/japplphysiol.00452.2004

E. Naureckas, P. Factor, O. Benjaminov, E. Hoffer, and V. Sriram, Pentoxifylline does not protect against hyperoxic lung injury in rats, European Respiratory Journal, vol.7, issue.8, pp.1397-1402, 1994.
DOI : 10.1183/09031936.94.07081397

U. Schwabe, M. Miyake, Y. Ohga, and J. Daly, 4-(3-Cyclopentyloxy-4- methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 39,59-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain, Mol Pharmacol, vol.12, pp.900-910, 1976.

C. Nielson, R. Vestal, R. Sturm, and R. Heaslip, Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst1, Journal of Allergy and Clinical Immunology, vol.86, issue.5, pp.801-808, 1990.
DOI : 10.1016/S0091-6749(05)80186-1

C. Schudt, S. Winder, S. Forderkunz, A. Hatzelmann, and V. Ullrich, Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.344, issue.6, pp.682-690, 1991.
DOI : 10.1007/BF00174752

G. Spoto, D. Giulio, C. Contento, A. , D. Stilio et al., Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats, Life Sciences, vol.63, issue.25, pp.349-353, 1998.
DOI : 10.1016/S0024-3205(98)00513-X

S. Iona, M. Cuomo, T. Bushnik, F. Naro, and C. Sette, Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain, Mol Pharmacol, vol.53, pp.23-32, 1998.

P. Wang, P. Wu, K. Ohleth, R. Egan, and M. Billah, Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils, Mol Pharmacol, vol.56, pp.170-174, 1999.

O. Saugstad, Bronchopulmonary dysplasia???oxidative stress and antioxidants, Seminars in Neonatology, vol.8, issue.1, pp.39-49, 2003.
DOI : 10.1016/S1084-2756(02)00194-X

G. Wagenaar, S. Horst, M. Van-gastelen, L. Leijser, and T. Mauad, Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress, Free Radical Biology and Medicine, vol.36, issue.6, pp.782-801, 2004.
DOI : 10.1016/j.freeradbiomed.2003.12.007

M. Vozzelli, S. Mason, M. Whorton, R. Auten, and . Jr, Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung, AJP: Lung Cellular and Molecular Physiology, vol.286, issue.3, pp.488-493, 2004.
DOI : 10.1152/ajplung.00414.2002

S. Jin and M. Conti, Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-?? responses, Proceedings of the National Academy of Sciences, vol.99, issue.11, pp.7628-7633, 2002.
DOI : 10.1073/pnas.122041599

O. Boucherat, M. Franco-montoya, C. Thibault, R. Incitti, and B. Chailley-heu, Gene expression profiling in lung fibroblasts reveals new players in alveolarization, Physiological Genomics, vol.32, issue.1, pp.128-141, 2007.
DOI : 10.1152/physiolgenomics.00108.2007

A. Pardo, K. Gibson, J. Cisneros, T. Richards, and Y. Yang, Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis, PLoS Medicine, vol.198, issue.9, p.251, 2005.
DOI : 10.1371/journal.pmed.0020251.sd002

V. Boswell-smith, M. Cazzola, and C. Page, Are phosphodiesterase 4 inhibitors just more theophylline?, Journal of Allergy and Clinical Immunology, vol.117, issue.6, pp.1237-1243, 2006.
DOI : 10.1016/j.jaci.2006.02.045

M. Barnette, M. Grous, L. Cieslinski, M. Burman, and S. Christensen, Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a highaffinity rolipram binding site, J Pharmacol Exp Ther, vol.273, pp.1396-1402, 1995.

J. Larson, M. Pino, L. Geiger, and C. Simeone, The Toxicity of Repeated Exposures to Rolipram, a Type IV Phosphodiesterase Inhibitor, in Rats, Pharmacology & Toxicology, vol.17, issue.1, pp.44-49, 1996.
DOI : 10.1111/j.1600-0773.1996.tb00178.x

N. Dagues, V. Pawlowski, C. Sobry, G. Hanton, and F. Borde, Investigation of the Molecular Mechanisms Preceding PDE4 Inhibitor-Induced Vasculopathy in Rats: Tissue Inhibitor of Metalloproteinase 1, a Potential Predictive Biomarker, Toxicological Sciences, vol.100, issue.1, pp.238-247, 2007.
DOI : 10.1093/toxsci/kfm161

S. Jin, F. Richard, W. Kuo, D. Ercole, A. Conti et al., Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice, Proceedings of the National Academy of Sciences, vol.96, issue.21, pp.11998-12003, 1999.
DOI : 10.1073/pnas.96.21.11998

B. Schmidt, R. Roberts, P. Davis, L. Doyle, and K. Barrington, Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.354, issue.20, pp.2112-2121, 2006.
DOI : 10.1056/NEJMoa054065

B. Schmidt, R. Roberts, P. Davis, L. Doyle, and K. Barrington, Long-Term Effects of Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.357, issue.19, pp.1893-1902, 2007.
DOI : 10.1056/NEJMoa073679

D. Massaro, N. Teich, S. Maxwell, G. Massaro, and P. Whitney, Postnatal development of alveoli. Regulation and evidence for a critical period in rats., Journal of Clinical Investigation, vol.76, issue.4, pp.1297-1305, 1985.
DOI : 10.1172/JCI112103

D. Massaro, E. Alexander, K. Reiland, E. Hoffman, and G. Massaro, Rapid onset of gene expression in lung, supportive of formation of alveolar septa, induced by refeeding mice after calorie restriction, AJP: Lung Cellular and Molecular Physiology, vol.292, issue.5, pp.1313-1326, 2007.
DOI : 10.1152/ajplung.00146.2006

W. Thompson and M. Appleman, Characterization of cyclic nucleotide phosphodiesterases of rat tissues, J Biol Chem, vol.246, pp.3145-3150, 1971.

T. Schmitz, E. Souil, R. Herve, C. Nicco, and F. Batteux, PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation, The Journal of Immunology, vol.178, issue.2, pp.1115-1121, 2007.
DOI : 10.4049/jimmunol.178.2.1115

URL : https://hal.archives-ouvertes.fr/inserm-00112464

S. Oger, C. Mehats, E. Dallot, F. Ferre, and M. Leroy, - and Cyclic Adenosine 3???,5???-Monophosphate-Dependent Pathway, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.12, pp.5524-5531, 2002.
DOI : 10.1210/jc.2002-020575

E. Huston, L. Pooley, P. Julien, G. Scotland, and I. Mcphee, The Human Cyclic AMP-specific Phosphodiesterase PDE-46 (HSPDE4A4B) Expressed in Transfected COS7 Cells Occurs as Both Particulate and Cytosolic Species That Exhibit Distinct Kinetics of Inhibition by the Antidepressant Rolipram, Journal of Biological Chemistry, vol.271, issue.49, pp.31334-31344, 1996.
DOI : 10.1074/jbc.271.49.31334

P. Waszak, M. Franco-montoya, M. Jacob, I. Deprez, and M. Levame, Effect of Intratracheal Adenoviral Vector Administration on Lung Development in Newborn Rats, Human Gene Therapy, vol.13, issue.15, pp.1873-1885, 2002.
DOI : 10.1089/104303402760372963

E. Weibel, L. Cruz-orive, R. Crystal, J. West, E. Weibel et al., Morphometric methods The lung: scientific foundations, pp.333-344, 1997.

T. Cooney and W. Thurlbeck, The radial alveolar count method of Emery and Mithal: a reappraisal 2--intrauterine and early postnatal lung growth., Thorax, vol.37, issue.8, pp.580-583, 1982.
DOI : 10.1136/thx.37.8.580

T. Cooney and W. Thurlbeck, The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth., Thorax, vol.37, issue.8, pp.572-579, 1982.
DOI : 10.1136/thx.37.8.572

T. Zeltner, J. Caduff, P. Gehr, J. Pfenninger, and P. Burri, The postnatal development and growth of the human lung. I. Morphometry, Respiration Physiology, vol.67, issue.3, pp.247-267, 1987.
DOI : 10.1016/0034-5687(87)90057-0